AC Immune SA (ACIU) Reports Q1 Loss of $0.15
AC Immune SA (NASDAQ: ACIU) reported Q1 EPS of ($0.15). Revenue for the quarter came in at $1.12 million versus the consensus estimate of $404.63 thousand.
For earnings history and earnings-related data on AC Immune SA (ACIU) click here.
